Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Minichromosome maintenance complex component 3 associated protein (MCM3AP) is an acetyltransferase that binds to and acetylates MCM3, a key DNA replication licensing factor[1][3][4]. MCM3AP inhibits the initiation of DNA replication by modifying MCM3, ensuring that DNA synthesis occurs only once per cell cycle. It interacts with components critical for chromatin structure and nuclear localization. While the MCM3AP gene is entirely contained within the GANP (germinal-center associated nuclear protein) locus, the two proteins are independently transcribed, localized to different subcellular compartments, and function distinctly. Dysfunction or allelic variation in MCM3AP is linked to neuropathies and intellectual disability. Despite its molecular role, MCM3AP is not a known target of approved drugs but is studied as a regulator of DNA replication, chromatin biology, and immune cell function[1][3][4].
Enzymatic acetylation of MCM3 (regulates DNA replication licensing and initiation by modifying MCM3)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Minichromosome maintenance complex component 3 associated protein (MCM3AP).